1.
Cost‑effectiveness analysis of hexaminolevulinate (Hexvix®) guided cystoscopy in Non‑Muscle Invasive Bladder Cancer patients (NMIBC) in Italy. FE. 2014;15(3). doi:10.7175/fe.v15i3.944